We observed that overexpression of USP22 remarkably strengthened the proliferative capacity of RALY-depleted HCC cells, as revealed by CCK-8 (Figure 7B) and EdU analyses (Figure 7C and 7D). Here, USP22 is linked to hepatocellular carcinoma.